<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36720488</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>02</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">2053-8790</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Lupus science &amp; medicine</Title><ISOAbbreviation>Lupus Sci Med</ISOAbbreviation></Journal><ArticleTitle>Molecular endotypes of type 1 and type 2 SLE.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e000861</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/lupus-2022-000861</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To character the molecular landscape of patients with type 1 and type 2 SLE by analysing gene expression profiles from peripheral blood.</AbstractText><AbstractText Label="METHODS">Full transcriptomic RNA sequencing was carried out on whole blood samples from 18 subjects with SLE selected by the presence of manifestations typical of type 1 and type 2 SLE. The top 5000 row variance genes were analysed by Multiscale Embedded Gene Co-expression Network Analysis to generate gene co-expression modules that were functionally annotated and correlated with various demographic traits, clinical features and laboratory measures.</AbstractText><AbstractText Label="RESULTS">Expression of specific gene co-expression modules correlated with individual features of type 1 and type 2 SLE and also effectively segregated samples from patients with type 1 SLE from those with type 2 SLE. Unique type 1 SLE enrichment included interferon, monocytes, T cells, cell cycle and neurotransmitter pathways, whereas unique type 2 SLE enrichment included B cells and metabolic and neuromuscular pathways. Gene co-expression modules of patients with type 2 SLE were identified in subsets of previously reported patients with inactive SLE and idiopathic fibromyalgia (FM) and also identified subsets of patients with active SLE with a greater frequency of severe fatigue.</AbstractText><AbstractText Label="CONCLUSION">Gene co-expression analysis successfully identified unique transcriptional patterns that segregate type 1 SLE from type 2 SLE and further identified type 2 molecular features in patients with inactive SLE or FM and with active SLE with severe fatigue.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Robl</LastName><ForeName>Robert</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-4589-7328</Identifier><AffiliationInfo><Affiliation>Bioinformatics, AMPEL BioSolutions, Charlottesville, Virginia, USA robertrobl@ampelbiosolutions.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eudy</LastName><ForeName>Amanda</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-3107-5545</Identifier><AffiliationInfo><Affiliation>Rheumatology, Duke University School of Medicine, Durham, North Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bachali</LastName><ForeName>Prathyusha S</ForeName><Initials>PS</Initials><Identifier Source="ORCID">0000-0001-7304-1987</Identifier><AffiliationInfo><Affiliation>Bioinformatics, AMPEL BioSolutions, Charlottesville, Virginia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rogers</LastName><ForeName>Jennifer L</ForeName><Initials>JL</Initials><Identifier Source="ORCID">0000-0001-5524-8642</Identifier><AffiliationInfo><Affiliation>Rheumatology, Duke University School of Medicine, Durham, North Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clowse</LastName><ForeName>Megan</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-8579-3470</Identifier><AffiliationInfo><Affiliation>Rheumatology, Duke University School of Medicine, Durham, North Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pisetsky</LastName><ForeName>David</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-3539-5351</Identifier><AffiliationInfo><Affiliation>Rheumatology, Duke University School of Medicine, Durham, North Carolina, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rheumatology, Durham Veterans Administration Medical Center, Durham, North Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lipsky</LastName><ForeName>Peter</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-9287-1676</Identifier><AffiliationInfo><Affiliation>Bioinformatics, AMPEL BioSolutions, Charlottesville, Virginia, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lupus Sci Med</MedlineTA><NlmUniqueID>101633705</NlmUniqueID><ISSNLinking>2053-8790</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>63231-63-0</RegistryNumber><NameOfSubstance UI="D012313">RNA</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020869" MajorTopicYN="N">Gene Expression Profiling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005356" MajorTopicYN="Y">Fibromyalgia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012313" MajorTopicYN="N">RNA</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">autoimmune diseases</Keyword><Keyword MajorTopicYN="N">fibromyalgia</Keyword><Keyword MajorTopicYN="N">inflammation</Keyword><Keyword MajorTopicYN="N">lupus erythematosus, systemic</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>31</Day><Hour>20</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36720488</ArticleId><ArticleId IdType="pmc">PMC9950972</ArticleId><ArticleId IdType="doi">10.1136/lupus-2022-000861</ArticleId><ArticleId IdType="pii">10/1/e000861</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ferretti C, la CA. Overview of the Pathogenesis of Systemic Lupus Erythematosus. In: Systemic lupus erythematosus. Elsevier, 2016: 55&#x2013;62.</Citation></Reference><Reference><Citation>Rogers JL, Eudy AM, Criscione-Schreiber LG, et al. . A novel approach to addressing fibromyalgia symptomatology in SLE. In: Abstracts. Lupus Foundation of America, 2019: A77.1&#x2013;A77.</Citation></Reference><Reference><Citation>Rogers JL, Eudy AM, Pisetsky D, et al. . Using clinical characteristics and patient-reported outcome measures to Categorize systemic lupus erythematosus subtypes. Arthritis Care Res 2021;73:386&#x2013;93. 10.1002/acr.24135</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acr.24135</ArticleId><ArticleId IdType="pubmed">31909888</ArticleId></ArticleIdList></Reference><Reference><Citation>Barraclough M, McKie S, Parker B, et al. . Altered cognitive function in systemic lupus erythematosus and associations with inflammation and functional and structural brain changes. Ann Rheum Dis 2019;78:934&#x2013;40. 10.1136/annrheumdis-2018-214677</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2018-214677</ArticleId><ArticleId IdType="pmc">PMC6585286</ArticleId><ArticleId IdType="pubmed">30979715</ArticleId></ArticleIdList></Reference><Reference><Citation>Hochberg MC. Updating the American College of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725. 10.1002/art.1780400928</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780400928</ArticleId><ArticleId IdType="pubmed">9324032</ArticleId></ArticleIdList></Reference><Reference><Citation>Petri M, Orbai A-M, Alarc&#xf3;n GS, et al. . Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 2012;64:2677&#x2013;86. 10.1002/art.34473</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.34473</ArticleId><ArticleId IdType="pmc">PMC3409311</ArticleId><ArticleId IdType="pubmed">22553077</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolfe F, Clauw DJ, Fitzcharles M-A, et al. . 2016 revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum 2016;46:319&#x2013;29. 10.1016/j.semarthrit.2016.08.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semarthrit.2016.08.012</ArticleId><ArticleId IdType="pubmed">27916278</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolfe F, Clauw DJ, Fitzcharles M-A, et al. . Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR preliminary diagnostic criteria for fibromyalgia. J Rheumatol 2011;38:1113&#x2013;22. 10.3899/jrheum.100594</Citation><ArticleIdList><ArticleId IdType="doi">10.3899/jrheum.100594</ArticleId><ArticleId IdType="pubmed">21285161</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolfe F, Clauw DJ, Fitzcharles M-A, et al. . The American College of rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res 2010;62:600&#x2013;10. 10.1002/acr.20140</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acr.20140</ArticleId><ArticleId IdType="pubmed">20461783</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolfe F, Walitt BT, Rasker JJ, et al. . The use of Polysymptomatic distress categories in the evaluation of fibromyalgia (FM) and FM severity. J Rheumatol 2015;42:1494&#x2013;501. 10.3899/jrheum.141519</Citation><ArticleIdList><ArticleId IdType="doi">10.3899/jrheum.141519</ArticleId><ArticleId IdType="pmc">PMC4755344</ArticleId><ArticleId IdType="pubmed">26077414</ArticleId></ArticleIdList></Reference><Reference><Citation>Gladman DD, Iba&#xf1;ez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002;29:288&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">11838846</ArticleId></ArticleIdList></Reference><Reference><Citation>Petri M, Hellmann D, Hochberg M. Validity and reliability of lupus activity measures in the routine clinic setting. J Rheumatol 1992;19:53&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">1556700</ArticleId></ArticleIdList></Reference><Reference><Citation>Song W-M, Zhang B. Multiscale embedded gene co-expression network analysis. PLoS Comput Biol 2015;11:e1004574. 10.1371/journal.pcbi.1004574</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1004574</ArticleId><ArticleId IdType="pmc">PMC4664553</ArticleId><ArticleId IdType="pubmed">26618778</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones KD, Gelbart T, Whisenant TC, et al. . Genome-wide expression profiling in the peripheral blood of patients with fibromyalgia. Clin Exp Rheumatol 2016;34:S89&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4888802</ArticleId><ArticleId IdType="pubmed">27157394</ArticleId></ArticleIdList></Reference><Reference><Citation>Petri M, Fu W, Ranger A, et al. . Association between changes in gene signatures expression and disease activity among patients with systemic lupus erythematosus. BMC Med Genomics 2019;12:4. 10.1186/s12920-018-0468-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12920-018-0468-1</ArticleId><ArticleId IdType="pmc">PMC6327466</ArticleId><ArticleId IdType="pubmed">30626389</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiche L, Jourde-Chiche N, Whalen E, et al. . Modular transcriptional repertoire analyses of adults with systemic lupus erythematosus reveal distinct type I and type II interferon signatures. Arthritis Rheumatol 2014;66:1583&#x2013;95. 10.1002/art.38628</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.38628</ArticleId><ArticleId IdType="pmc">PMC4157826</ArticleId><ArticleId IdType="pubmed">24644022</ArticleId></ArticleIdList></Reference><Reference><Citation>Szklarczyk D, Franceschini A, Wyder S, et al. . String v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res 2015;43:D447&#x2013;52. 10.1093/nar/gku1003</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gku1003</ArticleId><ArticleId IdType="pmc">PMC4383874</ArticleId><ArticleId IdType="pubmed">25352553</ArticleId></ArticleIdList></Reference><Reference><Citation>McKenzie AT, Katsyv I, Song W-M, et al. . DGCA: a comprehensive R package for differential gene correlation analysis. BMC Syst Biol 2016;10:106. 10.1186/s12918-016-0349-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12918-016-0349-1</ArticleId><ArticleId IdType="pmc">PMC5111277</ArticleId><ArticleId IdType="pubmed">27846853</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng X, Wu H, Grossman JM, et al. . Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus. Arthritis Rheum 2006;54:2951&#x2013;62. 10.1002/art.22044</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.22044</ArticleId><ArticleId IdType="pubmed">16947629</ArticleId></ArticleIdList></Reference><Reference><Citation>Labonte AC, Kegerreis B, Geraci NS, et al. . Identification of alterations in macrophage activation associated with disease activity in systemic lupus erythematosus. PLoS One 2018;13:e0208132. 10.1371/journal.pone.0208132</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0208132</ArticleId><ArticleId IdType="pmc">PMC6298676</ArticleId><ArticleId IdType="pubmed">30562343</ArticleId></ArticleIdList></Reference><Reference><Citation>Kegerreis B, Catalina MD, Bachali P, et al. . Machine learning approaches to predict lupus disease activity from gene expression data. Sci Rep 2019;9:9617. 10.1038/s41598-019-45989-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-45989-0</ArticleId><ArticleId IdType="pmc">PMC6610624</ArticleId><ArticleId IdType="pubmed">31270349</ArticleId></ArticleIdList></Reference><Reference><Citation>Catalina MD, Bachali P, Geraci NS, et al. . Gene expression analysis delineates the potential roles of multiple interferons in systemic lupus erythematosus. Commun Biol 2019;2:140. 10.1038/s42003-019-0382-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-019-0382-x</ArticleId><ArticleId IdType="pmc">PMC6478921</ArticleId><ArticleId IdType="pubmed">31044165</ArticleId></ArticleIdList></Reference><Reference><Citation>Tesser A, de Carvalho LM, Sandrin-Garcia P, et al. . Higher interferon score and normal complement levels may identify a distinct clinical subset in children with systemic lupus erythematosus. Arthritis Res Ther 2020;22:91. 10.1186/s13075-020-02161-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-020-02161-8</ArticleId><ArticleId IdType="pmc">PMC7183668</ArticleId><ArticleId IdType="pubmed">32334613</ArticleId></ArticleIdList></Reference><Reference><Citation>Postal M, Sinicato NA, Peli&#xe7;ari KO, et al. . Clinical and serological manifestations associated with interferon-&#x3b1; levels in childhood-onset systemic lupus erythematosus. Clinics 2012;67:157&#x2013;62. 10.6061/clinics/2012(02)11</Citation><ArticleIdList><ArticleId IdType="doi">10.6061/clinics/2012(02)11</ArticleId><ArticleId IdType="pmc">PMC3275113</ArticleId><ArticleId IdType="pubmed">22358241</ArticleId></ArticleIdList></Reference><Reference><Citation>Hubbard EL, Pisetsky DS, Lipsky PE. Anti-Rnp antibodies are associated with the interferon gene signature but not decreased complement levels in SLE. Ann Rheum Dis 2022;81:632&#x2013;43. 10.1136/annrheumdis-2021-221662</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2021-221662</ArticleId><ArticleId IdType="pubmed">35115332</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell A, Hepgul N, Nikkheslat N, et al. . Persistent fatigue induced by interferon-alpha: a novel, inflammation-based, proxy model of chronic fatigue syndrome. Psychoneuroendocrinology 2019;100:276&#x2013;85. 10.1016/j.psyneuen.2018.11.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psyneuen.2018.11.032</ArticleId><ArticleId IdType="pmc">PMC6350004</ArticleId><ArticleId IdType="pubmed">30567628</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta S, Tatouli IP, Rosen LB, et al. . Distinct functions of autoantibodies against interferon in systemic lupus erythematosus: a comprehensive analysis of anticytokine autoantibodies in common rheumatic diseases. Arthritis Rheumatol 2016;68:1677&#x2013;87. 10.1002/art.39607</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.39607</ArticleId><ArticleId IdType="pmc">PMC5391258</ArticleId><ArticleId IdType="pubmed">26815287</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma C, Xia Y, Yang Q, et al. . The contribution of macrophages to systemic lupus erythematosus. Clin Immunol 2019;207:1&#x2013;9. 10.1016/j.clim.2019.06.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2019.06.009</ArticleId><ArticleId IdType="pubmed">31255802</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsiari CG, Liossis S-NC, Sfikakis PP. The pathophysiologic role of monocytes and macrophages in systemic lupus erythematosus: a reappraisal. Semin Arthritis Rheum 2010;39:491&#x2013;503. 10.1016/j.semarthrit.2008.11.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semarthrit.2008.11.002</ArticleId><ArticleId IdType="pubmed">19147182</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett L, Palucka AK, Arce E, et al. . Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 2003;197:711&#x2013;23. 10.1084/jem.20021553</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20021553</ArticleId><ArticleId IdType="pmc">PMC2193846</ArticleId><ArticleId IdType="pubmed">12642603</ArticleId></ArticleIdList></Reference><Reference><Citation>Denny MF, Yalavarthi S, Zhao W, et al. . A distinct subset of proinflammatory neutrophils isolated from patients with systemic lupus erythematosus induces vascular damage and synthesizes type I IFNs. J Immunol 2010;184:3284&#x2013;97. 10.4049/jimmunol.0902199</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0902199</ArticleId><ArticleId IdType="pmc">PMC2929645</ArticleId><ArticleId IdType="pubmed">20164424</ArticleId></ArticleIdList></Reference><Reference><Citation>Caielli S, Athale S, Domic B, et al. . Oxidized mitochondrial nucleoids released by neutrophils drive type I interferon production in human lupus. J Exp Med 2016;213:697&#x2013;713. 10.1084/jem.20151876</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20151876</ArticleId><ArticleId IdType="pmc">PMC4854735</ArticleId><ArticleId IdType="pubmed">27091841</ArticleId></ArticleIdList></Reference><Reference><Citation>Catalina MD, Bachali P, Yeo AE, et al. . Patient ancestry significantly contributes to molecular heterogeneity of systemic lupus erythematosus. JCI Insight 2020;5:e140380. 10.1172/jci.insight.140380</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.140380</ArticleId><ArticleId IdType="pmc">PMC7455079</ArticleId><ArticleId IdType="pubmed">32759501</ArticleId></ArticleIdList></Reference><Reference><Citation>van Tilburg MAL, Parisien M, Boles RG, et al. . A genetic polymorphism that is associated with mitochondrial energy metabolism increases risk of fibromyalgia. Pain 2020;161:2860&#x2013;71. 10.1097/j.pain.0000000000001996</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000001996</ArticleId><ArticleId IdType="pmc">PMC7669626</ArticleId><ArticleId IdType="pubmed">32658146</ArticleId></ArticleIdList></Reference><Reference><Citation>Bax K, Isackson PJ, Moore M, et al. . Carnitine palmitoyl transferase deficiency in a university immunology practice. Curr Rheumatol Rep 2020;22:8. 10.1007/s11926-020-0879-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11926-020-0879-9</ArticleId><ArticleId IdType="pubmed">32067119</ArticleId></ArticleIdList></Reference><Reference><Citation>Meeus M, Nijs J, Hermans L, et al. . The role of mitochondrial dysfunctions due to oxidative and nitrosative stress in the chronic pain or chronic fatigue syndromes and fibromyalgia patients: peripheral and central mechanisms as therapeutic targets? Expert Opin Ther Targets 2013;17:1081&#x2013;9. 10.1517/14728222.2013.818657</Citation><ArticleIdList><ArticleId IdType="doi">10.1517/14728222.2013.818657</ArticleId><ArticleId IdType="pubmed">23834645</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Chen M, Jiang J. Mitochondrial dysfunction in neurodegenerative diseases and drug targets via apoptotic signaling. Mitochondrion 2019;49:35&#x2013;45. 10.1016/j.mito.2019.07.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mito.2019.07.003</ArticleId><ArticleId IdType="pubmed">31288090</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>